Is an Anticholinergic Agent Superior to a β2-Agonist in Improving Dyspnea and Exercise Limitation in COPD?

This publication has 13 references indexed in Scilit:

• Reanalysis of the 12-Minute Walk in Patients With Chronic Obstructive Pulmonary Disease
  Chest, 1994
• Bronchodilator Responses to Anticholinergic and Beta-Adrenergic Agents in Acute and Stable COPD
  Chest, 1991
• Dose Response to Ipratropium as a Nebulized Solution in Patients with Chronic Obstructive Pulmonary Disease: A Three-Center Study
  American Review of Respiratory Disease, 1989
• Acute Response to Bronchodilator
  Archives of internal medicine (1960), 1988
• Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma
  American Review of Respiratory Disease, 1987
• Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: A 90-day multi-center study
  The American Journal of Medicine, 1986
• Bronchodilator responses to nebulised ipratropium and salbutamol singly and in combination in chronic bronchitis.
  British Journal of Clinical Pharmacology, 1984
• The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis.
  Thorax, 1978
• Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease.
  BMJ, 1978
• Twelve-minute walking test for assessing disability in chronic bronchitis.
  BMJ, 1976